Inicio>>Signaling Pathways>> Proteases>> Drug Metabolite>>Quetiapine sulfoxide dihydrochloride

Quetiapine sulfoxide dihydrochloride

Catalog No.GC37057

El diclorhidrato de sulfÓxido de quetiapina (diclorhidrato de S-Óxido de quetiapina) es un metabolito principal de quetiapinem.

Products are for research use only. Not for human use. We do not sell to patients.

Quetiapine sulfoxide dihydrochloride Chemical Structure

Cas No.: 329218-11-3

Tamaño Precio Disponibilidad Cantidad
5mg
167,00 $
Disponible
10mg
278,00 $
Disponible
50mg
1.205,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Quetiapine sulfoxide dihydrochloride (Quetiapine S-oxide dihydrochloride) is a main metabolite of Quetiapinem. Quetiapine is a second-generation antipsychotic[1].

The Cmax value (mean±SD) is estimated for Quetiapine sulfoxide (77.3±32.4 ng/mL). The AUClast value is estimated for Quetiapine sulfoxide (1,286±458 ng•h/mL). For Quetiapine sulfoxide, metabolic ratio decreases with time, from 119% on average 2 hours after dosing to 30% on average 72 hours after dosing[1].

[1]. Remmerie B, et al. Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole. Clin Pharmacol Drug Dev. 2016 Nov;5(6):528-537.

Reseñas

Review for Quetiapine sulfoxide dihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Quetiapine sulfoxide dihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.